New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
10:00 EDTITCI, INCY, COV, WCIC, TRVN, RTEC, GOLD, NUTR, LJPC, KLIC, IVAC, HELI, EPE, APLOn The Fly: Analyst Initiation Summary
Atlas Pipeline Partners (APL) initiated with a Hold at Deutsche Bank... CHC Group (HELI) initiated with a Buy at UBS... EP Energy (EPE) initiated with an Overweight at JPMorgan... Intevac (IVAC) initiated with a Neutral at B. Riley... Kulicke & Soffa (KLIC) initiated with a Buy at B. Riley... La Jolla Pharmaceutical (LJPC) initiated with an Outperform at Wedbush... Nutraceutical (NUTR) initiated with an Outperform at Imperial Capital... Randgold Resources (GOLD) initiated with a Buy at UBS... Rudolph Technologies (RTEC) initiated with a Buy at B. Riley... Trevena (TRVN) initiated with an Outperform at JMP Securities... WCI Communities (WCIC) reinstated with an Outperform at Credit Suisse... Covidien (COV) initiated with a Buy at CRT Capital... Incyte (INCY) coverage assumed with a Buy at BofA/Merrill... Intra-Cellular (ITCI) initiated with an Outperform at Cowen.
News For APL;EPE;HELI;IVAC;KLIC;LJPC;NUTR;GOLD;RTEC;TRVN;WCIC;COV;INCY;ITCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 27, 2014
07:38 EDTEPEUS E&P sector downgraded to Neutral from Attractive at Goldman
Subscribe for More Information
07:23 EDTCOVAmerican College of Surgeons holds a conference
Subscribe for More Information
06:10 EDTEPEEP Energy downgraded to Neutral from Buy at Goldman
Goldman downgraded EP Energy to Neutral due to funding gap concerns. Price target is 16.
05:18 EDTHELICHC Group awarded long-term multi-field services contract
Total E&P UK is extending a decades-long relationship with CHC Helicopter in the North Sea, awarding CHC a long-term helicopter transportation contract to support Totalís offshore operations across the United Kingdom Continental Shelf , or UKCS. The contract calls for CHC to operate two Sikorsky S-92 and two Airbus EC225 helicopters on behalf of Total. The helicopters will fly from Aberdeen to Totalís Elgin-Franklin, Alwyn and Dunbar fields, as well as to the mobile drilling rigs Total E&P UK have across the UKCS. The contract is for up to seven years, includes options for up to two additional years, and will take effect in November. Totalís operations on the UKCS range from the Elgin-Franklin field, which is in the Central North Sea, about 200 kilometres east of Aberdeen, to the Alwyn field, situated 440 kilometres northeast of Aberdeen, and the Dunbar field, located 22 kilometres south of Alwyn. Total also has mobile drilling rigs on contract that operate across the UKCS from the Central North Sea to the West of Shetland region.
October 23, 2014
15:53 EDTLJPCLa Jolla's GCS-100 Phase 2a abstract released, says Jefferies
Subscribe for More Information
10:06 EDTTRVNSummer Street chief scientific officer holds an analyst/industry conference call
Subscribe for More Information
October 21, 2014
12:37 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
09:52 EDTCOVCovidien rises after Medtronic maintains merger date language
Shares of Covidien (COV) are rising in early trading after Medtronic (MDT), in its latest regulatory filing answering questions for shareholders regarding its proposed takeover of the Irish drugmaker, left its language regarding the expected closing date unchanged. WHAT'S NEW: In its most recent filing, Medtronic again stated, "As of the date of this joint proxy statement/prospectus, the transaction is expected to be completed late in the fourth calendar quarter of 2014 or early 2015. However, no assurance can be provided as to when or if the transaction will be completed. The required vote of Medtronic and Covidien shareholders to adopt the required shareholder proposals at their respective special meetings, as well as the necessary regulatory consents and approvals, must first be obtained and other conditions specified in the conditions appendix must be satisfied or, to the extent applicable, waived." ANALYST REACTION: Research firm BTIG says Medtronic's amended regulatory filing on the Covidien transaction increases the firm's confidence of the deal closing by early 2015. The firm adds it would be "stunned" to see Medtronic walk away from the merger after the company again showed commitment to the acquisition. WHAT'S NOTABLE: AbbVie (ABBV) last night confirmed that the company and Shire (SHPG), another Irish domiciled drugmaker, agreed to terminate their proposed merger. AbbVie said its decision was based upon its assessment of the September 22 notice issued by the U.S. Department of Treasury, which re-interpreted longstanding tax principles in a "uniquely selective manner designed specifically to destroy the financial benefits of these types of transactions." AbbVie continued that the Treasury notice "introduced an unacceptable level of risk and uncertainty given the magnitude of the proposed changes" and the stated intention of the department to continue to revise tax principles to further impact such "tax inversion" transactions. AbbVie noted that it has agreed to pay Shire a break fee of approximately $1.64B due to the deal falling through. PRICE ACTION: In early trading, shares of Covidien trading in New York rose 4% to $88.86, Medtronic advanced 1% to $64.57, Shires gained 0.7% to $185.82 and AbbVie added 1.4% to $55.16.
09:43 EDTCOVAmended filing increases confidence in Covidien deal at BTIG
BTIG says Medtronic's (MDT) amended regulatory filing on the Covidien (COV) transaction increases its confidence of the deal closing by early 2015. The firm adds it would be "stunned" to see Medtronic walk away from the merger after the company again showed commitment to the acquisition. Shares of Covidien are up 3% to $88.11 in early trading.
09:11 EDTCOVMedtronic keeps language unchanged on merger closing date
Medtronic in its latest regulatory filing answering questions for shareholders regarding its proposed takeover of Covidien (COV) left the language unchanged around the expected closing date. The company again stated, "As of the date of this joint proxy statement/prospectus, the transaction is expected to be completed late in the fourth calendar quarter of 2014 or early 2015. However, no assurance can be provided as to when or if the transaction will be completed. The required vote of Medtronic and Covidien shareholders to adopt the required shareholder proposals at their respective special meetings, as well as the necessary regulatory consents and approvals, must first be obtained and other conditions specified in the conditions appendix must be satisfied or, to the extent applicable, waived."
07:54 EDTINCYLeerink a buyer of Alkermes, ImmunoGen, Incyte
Subscribe for More Information
06:27 EDTTRVNTrevena management to meet with Needham
Subscribe for More Information
October 20, 2014
13:40 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
07:12 EDTCOVCongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
October 17, 2014
12:35 EDTCOVCovidien puts active on wide price movement
Covidien October 82, December 70 and January 75 puts are active on total put volume of 8K contracts (1K calls). November put option implied volatility is at 60, January is at 40, April is at 42; compared to its 26-week average of 25 according to Track Data. Active put volume suggests traders taking positions for large price movement.
10:51 EDTCOVOptions with increasing implied volatility
Options with increasing implied volatility: COV DISH HLT QEP GREK BKW BYI LLY DTV TIBX
10:00 EDTHELIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:02 EDTCOVCovidien granted preliminary injunction against Ethicon's Harmonic ACE+7
Subscribe for More Information
08:01 EDTINCYIncyte names Gryska CFO to succeed Hastings
Incyte announced the appointment of David Gryska as Executive Vice President and CFO, effective October 31. Gryska will succeed David Hastings, who has served as Incyteís Executive Vice President and CFO since October 2003. Hastings, who is leaving the company to pursue other opportunities, will remain with Incyte through the end of November and will work closely with Gryska to ensure a seamless transition.
07:02 EDTHELICHC Group downgraded to Market Perform from Outperform at Cowen
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use